Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/14/2014US8859466 Oxaspirocyclic spiro-substituted tetramic acid and tetronic acid derivatives
10/14/2014US8859290 Inhibitors of influenza endonuclease activity and tools for their discovery
10/14/2014US8859222 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
10/14/2014US8859207 Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
10/14/2014US8859022 Antihypertensive agents
10/14/2014US8859021 Skin appearance through gene manipulation
10/14/2014US8859015 Milk yield and/or milk quality improving agent, perinatal disease preventive or therapeutic agent, and reproductivity improving agent for ruminant
10/14/2014US8859014 Method of converting fustin to fisetin
10/14/2014US8859011 Calcium compositions
10/14/2014US8859003 Preparation of an enteric release system
10/14/2014US8859001 Fenoldopam formulations and pro-drug derivatives
10/14/2014US8858998 Thermoresponsive arginine-based hydrogels as biologic carriers
10/14/2014US8858997 Formulations and methods for lyophilization and lyophilates provided thereby
10/14/2014US8858996 Pharmaceutical compositions for the coordinated delivery of NSAIDS
10/14/2014US8858995 Methods and compositions for controlled delivery of phytochemical agents
10/14/2014US8858994 Pharmaceutical formulation comprising ezetimibe
10/14/2014US8858992 High drug load mesalazine sachet
10/14/2014US8858991 Delayed release oral pharmaceutical dosage forms comprising MGBG
10/14/2014US8858983 Antioxidants and antimicrobial accessories including antioxidants
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/14/2014US8858977 Drug delivery system
10/14/2014US8858976 Implantable paste and its use
10/14/2014US8858974 Device and methods for treating paranasal sinus conditions
10/14/2014US8858971 Epidermal cooling
10/14/2014US8858967 Dermatological cream-gels containing avermectin compounds
10/14/2014US8858965 Micelle encapsulation of a combination of therapeutic agents
10/14/2014US8858964 Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
10/14/2014US8858961 Compositions containing alpha-2-adrenergic agonist components
10/14/2014US8858945 Three-dimensional structure of complement receptor type 2 and uses thereof
10/14/2014US8858939 Ectopic pregnancy treatment
10/14/2014US8858924 Compositions and methods for treatment of hemorrhage
10/14/2014US8858922 Broad spectrum UVA stable, non-toxic, zinc oxide based complex
10/14/2014US8858919 Method of providing fast relief to a user of a nicotine chewing gum
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/14/2014US8858912 Frozen compositions and methods for piercing a substrate
10/14/2014US8858911 Phosphodiesterase 1-targeting tracers and methods
10/14/2014US8858210 Manufacture of variable density dosage forms utilizing radiofrequency energy
10/09/2014WO2014165851A1 Transient up-regulation of myc in b-cell lymphomas
10/09/2014WO2014165842A2 Nanoparticle formulations in biomarker detection
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014165823A1 Treatment of gastrointestinal and other disorders
10/09/2014WO2014165816A1 Compounds useful for the treatment of metabolic disorders and synthesis of the same
10/09/2014WO2014165815A2 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
10/09/2014WO2014165792A2 Macrolides and methods of their preparation and use
10/09/2014WO2014165786A1 Cabozantinib dosage form and use in the treatment of cancer
10/09/2014WO2014165779A1 Drug combinations to treat cancer
10/09/2014WO2014165746A1 Methods and compositions using adam10 inhibitors to treat bacterial infections
10/09/2014WO2014165736A2 Esters of 2-deoxy-monosaccharides with anti proliferative activity
10/09/2014WO2014165723A2 Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
10/09/2014WO2014165718A1 Combination therapy for the treatment of proliferative diseases
10/09/2014WO2014165713A2 Treatment of inflammatory conditions by modulation of hyaluronan and hyaluronidase activity
10/09/2014WO2014165704A1 Hepatitis c viral infection treatment using a combination of compounds
10/09/2014WO2014165672A1 Nanoparticle therapeutic agents, their formulations, and methods of their use
10/09/2014WO2014165660A1 Pharmaceutical formulations for subcutaneous administration of furosemide
10/09/2014WO2014165644A2 Combination treatments with sonic hedgehog inhibitors
10/09/2014WO2014165548A2 Indoline alkaloid compounds
10/09/2014WO2014165542A1 2',4'-fluoro nucleosides for the treatment of hcv
10/09/2014WO2014165482A1 Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers
10/09/2014WO2014165412A2 Methods and compositions for treating cancers having acquired resistance to chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
10/09/2014WO2014165307A2 Modulation of k2p channels
10/09/2014WO2014165303A1 Tiotropium dry powders
10/09/2014WO2014165263A1 Gamma-secretase modulators
10/09/2014WO2014165232A1 Compounds for treatment of cancer
10/09/2014WO2014165226A2 Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
10/09/2014WO2014165216A1 Diagnosing and treating cancer
10/09/2014WO2014165190A2 Compositions comprising docosapentaenoic acid and methods of use
10/09/2014WO2014165143A1 Dihydro-pyrrolopyridinone bromodomain inhibitors
10/09/2014WO2014165128A2 Hepatitis b antiviral agents
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014165126A2 Derivatized 3-styryl-cephalosporins
10/09/2014WO2014165113A1 Cross-linked hyaluronic acid threads for treatment of striae
10/09/2014WO2014165087A1 Mdr method and products for treating hiv/aids
10/09/2014WO2014165075A1 Antibacterial agents
10/09/2014WO2014165070A1 Substituted 2-azabicycles and their use as orexin receptor modulators
10/09/2014WO2014165065A1 Substituted piperidine compounds and their use as orexin receptor modulators
10/09/2014WO2014165057A1 Compositions and methods for treating infectious disease
10/09/2014WO2014164969A1 Treatment of cataplexy
10/09/2014WO2014164968A1 Novel compounds for the treatment of hepatitis c
10/09/2014WO2014164957A1 Nanoparticulate and macroparticulate formulations
10/09/2014WO2014164942A1 Dual mek/pi3k inhibitors and therapeutic methods using the same
10/09/2014WO2014164886A1 Prostanoid receptor agonist compounds and their use
10/09/2014WO2014164861A1 Onapristone polymorphic forms and methods of use
10/09/2014WO2014164844A1 Cathepsin inhibitors
10/09/2014WO2014164784A1 Hdac inhibitor polymorphic forms and methods of use
10/09/2014WO2014164780A1 Fused tetracyclic bromodomain inhibitors
10/09/2014WO2014164771A1 Bromodomain inhibitors
10/09/2014WO2014164767A1 Novel compounds and compositions for inhibition of fasn
10/09/2014WO2014164756A1 Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
10/09/2014WO2014164754A1 Injectable controlled release composition comprising high viscosity liquid carrier
10/09/2014WO2014164749A1 Novel compounds and compositions for inhibition of fasn
10/09/2014WO2014164736A1 Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
10/09/2014WO2014164730A2 Modulation of cellular dna repair activity to intercept malignancy
10/09/2014WO2014164729A1 Substituted tricyclic pyrazolo-pyrimidine compounds
10/09/2014WO2014164723A1 Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications
10/09/2014WO2014164712A1 Formation and uses of europium
10/09/2014WO2014164708A1 Histone dementhylase inhibitors
10/09/2014WO2014164682A1 Azaadamantane formate ester and process preparing azaadamantane derivatives
10/09/2014WO2014164678A1 Translocator protein imaging agents; methods of manufacture, and methods of use thereof
10/09/2014WO2014164669A1 Improved medical device
10/09/2014WO2014164667A1 Dengue and west nile virus protease inhibitors
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 7860